Maetzold Derek J 的 Form 4 申報
Castle Biosciences Inc（CSTL），2026/5/11 申報
- 申報編號
- 0001628280-26-033446
- 申報時間
- 2026/5/11
- 交易日
- 2026/5/7
- 申報延遲
- 4 天
- 10b5-1 計畫
- 有勾選
這份申報列了 15 筆非衍生性交易、1 筆衍生性交易。公開市場賣出合計 $21.8 萬。交易後 4 天申報。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Maetzold Derek JCIK 0001239501 | 董事、高階主管（總裁、執行長） |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
| 交易日 | 證券 | 交易 | 股數 | 價格 | 金額 | 交易後持股 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2026/5/7 | Common Stock | M行使選擇權取得 | +6,214 | $2.39 | +$14,851.46 | 27,693 | 直接 | |
| 2026/5/7 | Common Stock | S賣出處分 | −5,308 | $22.08F2 | −$117,200.64 | 22,385 | 直接 | |
| 2026/5/7 | Common Stock | S賣出處分 | −1,159 | $22.08F2 | −$25,590.72 | 46,336 | 間接 | |
| 2026/5/7 | Common Stock | S賣出處分 | −985 | $22.08F2 | −$21,748.8 | 39,382 | 間接 | |
| 2026/5/7 | Common Stock | S賣出處分 | −237 | $22.08F2 | −$5,232.96 | 2,265 | 間接 | |
| 2026/5/7 | Common Stock | S賣出處分 | −237 | $22.08F2 | −$5,232.96 | 2,265 | 間接 | |
| 2026/5/7 | Common Stock | S賣出處分 | −237 | $22.08F2 | −$5,232.96 | 2,265 | 間接 | |
| 2026/5/7 | Common Stock | S賣出處分 | −237 | $22.08F2 | −$5,232.96 | 2,265 | 間接 | |
| 2026/5/7 | Common Stock | S賣出處分 | −906 | $22.59F9 | −$20,466.54 | 21,479 | 直接 | |
| 2026/5/7 | Common Stock | S賣出處分 | −198 | $22.59F9 | −$4,472.82 | 46,138 | 間接 | |
| 2026/5/7 | Common Stock | S賣出處分 | −168 | $22.59F9 | −$3,795.12 | 39,214 | 間接 | |
| 2026/5/7 | Common Stock | S賣出處分 | −41 | $22.59F9 | −$926.19 | 2,224 | 間接 | |
| 2026/5/7 | Common Stock | S賣出處分 | −41 | $22.59F9 | −$926.19 | 2,224 | 間接 | |
| 2026/5/7 | Common Stock | S賣出處分 | −41 | $22.59F9 | −$926.19 | 2,224 | 間接 | |
| 2026/5/7 | Common Stock | S賣出處分 | −41 | $22.59F9 | −$926.19 | 2,224 | 間接 |
衍生性證券（表 II）
選擇權、認股權證、限制型股票單位等。股數是標的股票的股數；單價與金額是衍生證券本身的價格，交易後持有是衍生證券的單位數。
| 交易日 | 證券 | 交易 | 標的股數 | 單價 | 金額 | 交易後持有 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2026/5/7 | Common Stock | M行使選擇權處分 | −6,214 | $0.00 | $0 | 754 | 直接 |
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F2
This transaction was executed in multiple trades at prices ranging from $21.520 to $22.515, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
表 I 有 7 筆交易的價格引用這則附註。
- F9
This transaction was executed in multiple trades at prices ranging from $22.520 to $22.680, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
表 I 有 7 筆交易的價格引用這則附註。